Sara B Ahmed, MD | |
2905 Hylan Boulevard, Staten Island, NY 10306-4653 | |
(718) 351-1212 | |
(718) 351-4114 |
Full Name | Sara B Ahmed |
---|---|
Gender | Female |
Speciality | Pulmonary Disease |
Experience | 19 Years |
Location | 2905 Hylan Boulevard, Staten Island, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679732507 | NPI | - | NPPES |
03304794 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 258472 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Staten Island University Hospital | Staten island, NY | Hospital |
Richmond University Medical Center | Staten island, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Amboy Medical Practice Pc | 2860538170 | 129 |
Richmond Pulmonary Medicine Pc | 3678464484 | 2 |
News Archive
Multiple sclerosis (MS) is caused by immune cells that activate a cascade of chemicals in the brain, attacking and degrading the insulation that keeps neuronal signals moving. These chemicals, called cytokines, drive the inflammation in the brain, attracting more immune cells, and causing the debilitating disease marked by loss of neurological function.
Endo Pharmaceuticals announced today that it has entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
The community prevalence of attenuated psychosis syndrome is sufficient to make it a valid addition to the DSM-5, but only with revisions to the current criteria, findings from the BEAR Study show.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 2 trial of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
› Verified 9 days ago
Entity Name | Richmond Pulmonary Medicine Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972547271 PECOS PAC ID: 3678464484 Enrollment ID: O20040322001518 |
News Archive
Multiple sclerosis (MS) is caused by immune cells that activate a cascade of chemicals in the brain, attacking and degrading the insulation that keeps neuronal signals moving. These chemicals, called cytokines, drive the inflammation in the brain, attracting more immune cells, and causing the debilitating disease marked by loss of neurological function.
Endo Pharmaceuticals announced today that it has entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
The community prevalence of attenuated psychosis syndrome is sufficient to make it a valid addition to the DSM-5, but only with revisions to the current criteria, findings from the BEAR Study show.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 2 trial of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
› Verified 9 days ago
Entity Name | Amboy Medical Practice Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700037975 PECOS PAC ID: 2860538170 Enrollment ID: O20090930000024 |
News Archive
Multiple sclerosis (MS) is caused by immune cells that activate a cascade of chemicals in the brain, attacking and degrading the insulation that keeps neuronal signals moving. These chemicals, called cytokines, drive the inflammation in the brain, attracting more immune cells, and causing the debilitating disease marked by loss of neurological function.
Endo Pharmaceuticals announced today that it has entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
The community prevalence of attenuated psychosis syndrome is sufficient to make it a valid addition to the DSM-5, but only with revisions to the current criteria, findings from the BEAR Study show.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 2 trial of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Sara B Ahmed, MD 2905 Hylan Boulevard, Staten Island, NY 10306-4653 Ph: (718) 351-1212 | Sara B Ahmed, MD 2905 Hylan Boulevard, Staten Island, NY 10306-4653 Ph: (718) 351-1212 |
News Archive
Multiple sclerosis (MS) is caused by immune cells that activate a cascade of chemicals in the brain, attacking and degrading the insulation that keeps neuronal signals moving. These chemicals, called cytokines, drive the inflammation in the brain, attracting more immune cells, and causing the debilitating disease marked by loss of neurological function.
Endo Pharmaceuticals announced today that it has entered into a definitive agreement to acquire Qualitest Pharmaceuticals, a leading, privately held generics company in the U.S., for approximately $1.2 billion in cash.
The community prevalence of attenuated psychosis syndrome is sufficient to make it a valid addition to the DSM-5, but only with revisions to the current criteria, findings from the BEAR Study show.
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 2 trial of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
› Verified 9 days ago
Liliane Sarkis Deeb, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4106 Hylan Blvd, Staten Island, NY 10308 Phone: 718-226-7855 Fax: 718-227-5814 | |
Deepak Vadada, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1050 Clove Rd, Staten Island, NY 10301 Phone: 718-816-6440 Fax: 718-816-3611 | |
Dr. Samantha Maria Lee, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-9510 Fax: 718-226-3473 | |
Dr. Jean Chalhoub, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Avenue, Department Of Internal Medicine, Staten Island, NY 10305 Phone: 718-226-8855 | |
Dr. Gustave Stephen Drivas, M.D., Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5405 Hylan Blvd, Staten Island, NY 10312 Phone: 718-948-3890 Fax: 718-948-3961 | |
Dr. Beatrice Nogueira, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-6902 Fax: 718-226-6844 | |
Dr. Felicia Tenedios, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 South Ave Ste 204, Staten Island, NY 10314 Phone: 718-447-0055 Fax: 718-876-5212 |